The 6th ESMO Symposium on Signalling Pathways 2018 is organised by leading professionals in the field, with objective to provide education and in-depth updates on the latest scientific developments on a personalised approach to cancer treatment. Main Theme: Focusing on Educational but will also present some recent advancement on CDK inhibitors and ongoing research on the topic. All companies with an interest in this theme are encouraged both to support this event and actively participate in the scientific programme.
The 6th ESMO Symposium on Signalling Pathways 2018 is in partnership with the European Association for Cancer Research (EACR).
Fast Facts: ESMO Symposium on Signalling Pathways 2018
- No parallel sessions
- Interactive Q&A time after each educational session
- Possibility to host a satellite symposium
- An internationally renowned faculty
- Excellent networking event for Industry
Italian Agency (AIFA applications)
The appointed agency to collect on ESMO behalf all applications from the Pharmaceutical Companies and file them with AIFA (Italian Drug Agency) is:
AIM Group International – AIM Education S.r.l.
Via G. Ripamonti, 129
20141 Milan, Italy
Contact: Valentina Disabato / Cristina Ghidoli
E-mail: aifa@aimgroup.eu
How can I participate in the ESMO Symposium on Signalling Pathways?
At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our congress
Contact the ESMO Strategic Partnerships Team for more details. We look forward to hearing from you!
Who has already signed up?
Silver Sponsor
Pfizer
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.